Renaissance Technologies Portfolio holdings
Renaissance Technologies LLC, founded in 1982 by mathematician James Simons as Monemetrics and headquartered in East Setauket, New York, is a legendary quantitative hedge fund managing around $65 billion in assets as of late 2024, renowned for its pioneering use of mathematical models and algorithms in trading. Starting with currency trading and evolving into a secretive powerhouse under its flagship Medallion Fund—launched in 1988—the firm employs PhDs, physicists, and computer scientists to analyze vast datasets, executing high-frequency trades across equities, futures, and derivatives with returns averaging over 66% annually before fees from 1988 to 2018. Simons, who stepped down as chairman in 2021, built a culture of intellectual rigor, limiting Medallion to employees and insiders since 1993 while offering institutional funds like the Renaissance Institutional Equities Fund (RIEF) to outsiders. Now led by Peter Brown and Robert Mercer’s successors, Renaissance remains a benchmark for quant investing, blending academic precision with a low-profile, extraordinarily profitable legacy despite occasional regulatory scrutiny.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Eli Lilly
LLY
|
+$671M |
| 2 |
McDonald's
MCD
|
+$636M |
| 3 |
TSMC
TSM
|
+$515M |
| 4 |
NVO
Novo Nordisk
NVO
|
+$465M |
| 5 |
Colgate-Palmolive
CL
|
+$458M |
Top Sells
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 14.45% |
| 2 | Healthcare | 11.94% |
| 3 | Consumer Discretionary | 11.58% |
| 4 | Consumer Staples | 10.68% |
| 5 | Financials | 9.61% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
401
Alkermes
ALKS
$8.78B
| $22.8M | 0.06% |
+794,686
| New | +$23.2M |
|
|
KATE
402
DELISTED
Kate Spade & Company
KATE
| $22.7M | 0.06% |
+1,017,200
| New | +$21.7M |
|
|
KKD
403
DELISTED
KRISPY KREME DOUGHNUTS INC
KKD
| $22.5M | 0.06% |
+1,290,864
| New | +$19.3M |
|
404
RPM International
RPM
$13.9B
| $22.5M | 0.06% |
+703,200
| New | +$22.6M |
|
|
SLXP
405
DELISTED
SALIX PHARMACEUTICALS LTD DEL
SLXP
| $22.4M | 0.06% |
+338,319
| New | +$19.3M |
|
406
AbbVie
ABBV
$458B
| $22.3M | 0.06% |
+540,300
| New | +$23.6M |
|
|
CBST
407
DELISTED
CUBIST PHARMACEUTICALS INC
CBST
| $22.3M | 0.06% |
+462,220
| New | +$22.7M |
|
|
SWFT
408
DELISTED
Swift Transportation Company
SWFT
| $22.3M | 0.06% |
+1,348,800
| New | +$20.7M |
|
|
CBL
409
DELISTED
CBL& Associates Properties, Inc.
CBL
| $22.3M | 0.06% |
+1,039,417
| New | +$24.7M |
|
|
LPT
410
DELISTED
Liberty Property Trust
LPT
| $22.2M | 0.06% |
+601,800
| New | +$24.6M |
|
|
TIBX
411
DELISTED
TIBCO SOFTWARE INC
TIBX
| $22.1M | 0.06% |
+1,034,665
| New | +$21.2M |
|
412
Federal Realty Investment Trust
FRT
$11B
| $22.1M | 0.06% |
+213,400
| New | +$23.6M |
|
|
FNSR
413
DELISTED
Finisar Corp
FNSR
| $22M | 0.06% |
+1,300,210
| New | +$17.7M |
|
|
FLY
414
DELISTED
Fly Leasing Limited
FLY
| $22M | 0.06% |
+1,306,600
| New | +$20.9M |
|
|
AXE
415
DELISTED
Anixter International Inc
AXE
| $22M | 0.06% |
+290,300
| New | +$21.2M |
|
416
Ciena
CIEN
$51.9B
| $22M | 0.06% |
+1,131,405
| New | +$18.8M |
|
417
B&G Foods
BGS
$292M
| $22M | 0.06% |
+644,800
| New | +$19.7M |
|
418
MGIC Investment
MTG
$6.36B
| $21.9M | 0.06% |
+3,606,400
| New | +$20.5M |
|
419
Tanger
SKT
$4.8B
| $21.9M | 0.06% |
+654,000
| New | +$23.5M |
|
420
Cracker Barrel
CBRL
$1.17B
| $21.9M | 0.06% |
+230,900
| New | +$20.1M |
|
421
Cogent Communications
CCOI
$597M
| $21.8M | 0.06% |
+774,600
| New | +$21.6M |
|
422
Bunge Global
BG
$22.8B
| $21.6M | 0.06% |
+305,400
| New | +$21.5M |
|
423
Ross Stores
ROST
$77.5B
| $21.6M | 0.06% |
+665,928
| New | +$21.3M |
|
424
Leidos
LDOS
$14.4B
| $21.6M | 0.06% |
+626,778
| New | +$22.3M |
|
|
FCE.A
425
DELISTED
Forest City Realty Trust, Inc.
FCE.A
| $21.5M | 0.06% |
+1,199,400
| New | +$22.1M |
|
Similar funds
Renaissance Technologies's Q2 2013 Portfolio in Review
Q2 2013 is the first quarter with a 13F filing on record for Renaissance Technologies, which disclosed 2,756 positions worth $38.1B. Its ten largest holdings account for 11% of the portfolio.
Its largest position is Eli Lilly: 12,326,205 shares worth $605M.
By sector, the portfolio is most concentrated in Technology at 14% of assets, followed by Healthcare and Consumer Discretionary.
- Renaissance Technologies's largest Q2 2013 buy was Eli Lilly: 12,326,205 shares worth $605M.
- Renaissance Technologies's ten largest holdings make up 11% of its $38.1B portfolio in Q2 2013.
- Renaissance Technologies disclosed 2,756 positions in Q2 2013, its first 13F filing on record.
Based on Renaissance Technologies's 13F filing for Q2 2013, filed 12 Aug 2013.